Dylan Trundell

853 total citations · 1 hit paper
21 papers, 210 citations indexed

About

Dylan Trundell is a scholar working on Genetics, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Dylan Trundell has authored 21 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Dylan Trundell's work include Genetic Neurodegenerative Diseases (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Dylan Trundell is often cited by papers focused on Genetic Neurodegenerative Diseases (4 papers), Neurogenetic and Muscular Disorders Research (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Dylan Trundell collaborates with scholars based in United Kingdom, United States and Switzerland. Dylan Trundell's co-authors include Asha Hareendran, Ksenija Gorni, David Cella, Floortje van Nooten, Ingela Wiklund, Michelle Mocarski, Ronald B. Postuma, Kirsten I. Taylor, Fredric O. Finkelstein and Gennaro Pagano and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Dylan Trundell

19 papers receiving 207 citations

Hit Papers

Prasinezumab slows motor progression in rapidly progressi... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
    2024 56 citations Gennaro Pagano, Kirsten I. Taylor et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dylan Trundell United Kingdom 8 66 53 51 35 34 21 210
Seok‐Jin Choi South Korea 8 115 1.7× 34 0.6× 46 0.9× 15 0.4× 36 1.1× 35 237
M.Á. Rubio Spain 9 116 1.8× 46 0.9× 19 0.4× 26 0.7× 25 0.7× 23 194
Toshinori Nakamura Japan 6 45 0.7× 21 0.4× 22 0.4× 41 1.2× 101 3.0× 29 333
Nisaharan Srikandarajah United Kingdom 10 79 1.2× 37 0.7× 36 0.7× 13 0.4× 20 0.6× 30 354
Giuseppe Fuda Italy 11 221 3.3× 119 2.2× 45 0.9× 23 0.7× 105 3.1× 27 353
Nadja Maria Jorge Asano Brazil 11 148 2.2× 7 0.1× 23 0.5× 16 0.5× 32 0.9× 37 302
Hoong‐Wei Gan United Kingdom 10 79 1.2× 72 1.4× 27 0.5× 20 0.6× 28 0.8× 31 285
Akshay Save United States 7 36 0.5× 33 0.6× 11 0.2× 22 0.6× 16 0.5× 14 208
Antonino Lupica Italy 10 257 3.9× 29 0.5× 28 0.5× 11 0.3× 54 1.6× 41 378
Arianna Manini Italy 10 110 1.7× 41 0.8× 45 0.9× 9 0.3× 136 4.0× 24 299

Countries citing papers authored by Dylan Trundell

Since Specialization
Citations

This map shows the geographic impact of Dylan Trundell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan Trundell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan Trundell more than expected).

Fields of papers citing papers by Dylan Trundell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dylan Trundell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan Trundell. The network helps show where Dylan Trundell may publish in the future.

Co-authorship network of co-authors of Dylan Trundell

This figure shows the co-authorship network connecting the top 25 collaborators of Dylan Trundell. A scholar is included among the top collaborators of Dylan Trundell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dylan Trundell. Dylan Trundell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagano, Gennaro, Dylan Trundell, Tanya Simuni, et al.. (2025). Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials. npj Parkinson s Disease. 11(1). 193–193.
2.
Trundell, Dylan, Evan Davies, Stefano Zanigni, et al.. (2025). Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III. Journal of Parkinson s Disease. 15(1). 97–110. 2 indexed citations
3.
Pagano, Gennaro, Kirsten I. Taylor, Tanya Simuni, et al.. (2024). Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease. Nature Medicine. 30(4). 1096–1103. 56 indexed citations breakdown →
4.
Murray, Lindsey, Louis S. Matza, Sonya Eremenco, et al.. (2022). Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare Disease. Value in Health. 26(4). 547–553. 7 indexed citations
5.
Zanigni, Stefano, Dylan Trundell, Annabelle Monnet, et al.. (2022). Estimating the meaningful within-patient change threshold for the MDS-UPDRS Part III (P1-1.Virtual). Neurology. 98(18_supplement). 1 indexed citations
6.
Trundell, Dylan, Anne Skalicky, Hannah Staunton, et al.. (2021). Development of the SMA independence scale–upper limb module (SMAIS–ULM): A novel scale for individuals with Type 2 and non-ambulant Type 3 SMA. Journal of the Neurological Sciences. 432. 120059–120059. 18 indexed citations
7.
Thomann, Alessandra E., Dylan Trundell, Florian Lipsmeier, et al.. (2021). Self‐Report versus Clinician Examination in Early Parkinson's Disease. Movement Disorders. 37(3). 585–597. 18 indexed citations
8.
9.
10.
11.
Trundell, Dylan, Giuseppe Palermo, Scott Schobel, et al.. (2019). Defining Clinically Meaningful Change on the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) (P1.8-043). Neurology. 92(15_supplement). 4 indexed citations
12.
Trundell, Dylan, Giuseppe Palermo, Jeffery D. Long, et al.. (2019). Using functional status to aid interpretation of the composite unified huntington’s disease rating scale (cUHDRS) scores in patients with huntington’s disease (HD). Journal of the Neurological Sciences. 405. 311–311. 1 indexed citations
13.
Finkelstein, Fredric O., Floortje van Nooten, Ingela Wiklund, Dylan Trundell, & David Cella. (2018). Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. Health and Quality of Life Outcomes. 16(1). 111–111. 26 indexed citations
14.
Trundell, Dylan, Giuseppe Palermo, Scott Schobel, et al.. (2018). F23 Validity, reliability, ability to detect change and meaningful within-patient change of the CUHDRS. A48.1–A48. 3 indexed citations
15.
Schobel, Scott, Giuseppe Palermo, Dylan Trundell, et al.. (2018). J02 A global development program testing RG6042, an anti-sense oligonucleotide, for the treatment of early manifest huntington’s disease (hd). Clinical Therapeutics. A98.1–A98. 2 indexed citations
16.
17.
Nooten, Floortje van, Ingela Wiklund, Dylan Trundell, & David Cella. (2016). PSYCHOMETRIC EVALUATION OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY–ANEMIA (FACT-AN) IN DIALYSIS AND NON-DIALYSIS PATIENTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE. Value in Health. 19(3). A91–A91. 2 indexed citations
18.
Hareendran, Asha, et al.. (2015). Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument. International Journal of COPD. 10. 475–475. 30 indexed citations
19.
Arnold, Bernhard, et al.. (2014). Translation and Linguistic Validation of Two COPD Symptom Diaries (Nicsi And Emsci) for Use in 14 Countries. Value in Health. 17(7). A600–A600. 3 indexed citations
20.
Rhee, Frits van, Corey Casper, Margaret Vernon, et al.. (2014). Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36. Blood. 124(21). 4469–4469. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seok‐Jin Choi Breakdown of academic impact, for papers by M.Á. Rubio Breakdown of academic impact, for papers by Toshinori Nakamura Breakdown of academic impact, for papers by Nisaharan Srikandarajah Breakdown of academic impact, for papers by Giuseppe Fuda Breakdown of academic impact, for papers by Nadja Maria Jorge Asano Breakdown of academic impact, for papers by Hoong‐Wei Gan Breakdown of academic impact, for papers by Akshay Save Breakdown of academic impact, for papers by Antonino Lupica Breakdown of academic impact, for papers by Arianna Manini
Rankless by CCL
2026